Literature for isoleucyl-thiazolidide (S09.001, S09.003 inhibitor)

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2008
1. Augstein,P., Berg,S., Heinke,P., Altmann,S., Salzsieder,E., Demuth,H.U. and Freyse,E.J.
   Efficacy of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide (P32/98) in fatty Zucker rats with incipient and manifest impaired glucose tolerance
   Diabetes Obes Metab10, 850-861. PubMed  Europe PubMed DOI  I
2007
2. Thornberry,N.A. and Weber,A.E.
   Discovery of JANUVIA (Sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
   Curr Top Med Chem7, 557-568. PubMed  Europe PubMed DOI  I
2005
3. Demuth,H.U., McIntosh,C.H. and Pederson,R.A.
   Type 2 diabetes - therapy with dipeptidyl peptidase IV inhibitors
   Biochim Biophys Acta Proteins Proteom1751, 33-44. PubMed  Europe PubMed DOI  I
2003
4. Beconi,M.G., Mao,A., Liu,D.Q., Kochansky,C., Pereira,T., Raab,C., Pearson,P. and Lee Chiu,S.H.
   Metabolism and pharmacokinetics of a dipeptidyl peptidase IV inhibitor in rats, dogs, and monkeys with selective carbamoyl glucuronidation of the primary amine in dogs
   Drug Metab Dispos31, 1269-1277. PubMed  Europe PubMed DOI  I
2001
5. [YEAR:12-1-2001]Pospisilik,J.A., Hinke,S.A., Pederson,R.A., Hoffmann,T., Rosche,F., Schlenzig,D., Glund,K., Heiser,U., McIntosh,C.H. and Demuth,H.
   Metabolism of glucagon by dipeptidyl peptidase IV (CD26)
   Regul Pept96, 133-141. PubMed  Europe PubMed DOI  I